Carnitene (L-Carnitine or Levocarnitine) is one of 2 small molecule programs targeting Type 2 Diabetic Patients. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
1 competitor in Type 2 Diabetic Patients
Carnitene (L-Carnitine or Levocarnitine)
Metformin /day
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details